According to Sumitomo Pharma 's latest financial reports and stock price the company's current Operating Margin is 8.85%. At the end of 2022 the company had an Operating Margin of 14.81%.
Year | Operating Margin | Change |
---|---|---|
2022 | 14.81% | -1.82% |
2021 | 15.09% | -13.23% |
2020 | 17.39% | 22.78% |
2019 | 14.16% | -22.09% |
2018 | 18.18% | 58.49% |
2017 | 11.47% | 16.91% |
2016 | 9.81% | 7.94% |
2015 | 9.09% | 1.53% |
2014 | 8.95% | 71.44% |
2013 | 5.22% | 12.06% |
2012 | 4.66% | -29.4% |
2011 | 6.60% | -37.77% |
2010 | 10.61% | -12.94% |
2009 | 12.18% | -22.43% |
2008 | 15.70% | 6.78% |
2007 | 14.71% | 40.72% |
2006 | 10.45% | 56.59% |
2005 | 6.67% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.